Moreover, D-2-HG induced DNA hypermethylation in gliomas results in silencing of programmed cell death-1 (PD-1) and its ligand (PDL-1) compared to IDH wild-type gliomas, which implies a stronger T-cell activation [92]. The gene discussed is IDH2; the disease is central nervous system cancer.